These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29359976)

  • 21. Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy.
    Fortin JS; Hetak AA; Duggan KE; Burglass CM; Penticoff HB; Schott HC
    Sci Rep; 2021 Aug; 11(1):16036. PubMed ID: 34362943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the effects of age and pituitary pars intermedia dysfunction on corneal sensitivity in horses.
    Miller C; Utter ML; Beech J
    Am J Vet Res; 2013 Jul; 74(7):1030-5. PubMed ID: 23802675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
    Copas VE; Durham AE
    Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.
    Horn R; Bertin FR
    J Vet Intern Med; 2019 Sep; 33(5):2249-2256. PubMed ID: 31498947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease.
    McFarlane D
    Ageing Res Rev; 2007 May; 6(1):54-63. PubMed ID: 17374512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
    Beech J; Boston RC; McFarlane D; Lindborg S
    J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of pituitary histomorphometry with dopamine and dopamine D2 receptor expression in horses with pituitary pars intermedia dysfunction.
    Huang L; Palmieri C; Bertin FR
    Res Vet Sci; 2022 Dec; 152():427-433. PubMed ID: 36126509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of muscle atrophy and impact of treatment with pergolide in horses with pituitary pars intermedia dysfunction and muscle atrophy.
    Banse HE; Whitehead AE; McFarlane D; Chelikani PK
    Domest Anim Endocrinol; 2021 Jul; 76():106620. PubMed ID: 33740552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses.
    Hart KA; Wochele DM; Norton NA; McFarlane D; Wooldridge AA; Frank N
    J Vet Intern Med; 2016; 30(2):653-63. PubMed ID: 26860336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic frequency, response to therapy, and long-term prognosis among horses and ponies with pituitary par intermedia dysfunction, 1993-2004.
    Rohrbach BW; Stafford JR; Clermont RS; Reed SM; Schott HC; Andrews FM
    J Vet Intern Med; 2012; 26(4):1027-34. PubMed ID: 22524260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
    Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE
    Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between hyperinsulinaemia and laminitis severity at the time of pituitary pars intermedia dysfunction diagnosis.
    Tadros EM; Fowlie JG; Refsal KR; Marteniuk J; Schott HC
    Equine Vet J; 2019 Jan; 51(1):52-56. PubMed ID: 29761574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perianesthetic development of diaphragmatic hernia in a horse with equine pituitary pars intermedia dysfunction (PPID).
    Shepard MK; Lee WL; Eggleston RB
    Can Vet J; 2015 Jan; 56(1):48-52. PubMed ID: 25565714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of dynamic testing for pituitary pars intermedia dysfunction diagnosis in donkeys.
    Mejia-Pereira S; Perez-Ecija A; Buchanan BR; Toribio RE; Mendoza FJ
    Equine Vet J; 2019 Jul; 51(4):481-488. PubMed ID: 30362589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.
    Donaldson MT; Jorgensen AJ; Beech J
    J Am Vet Med Assoc; 2004 Apr; 224(7):1123-7. PubMed ID: 15074858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basal glucose metabolism and peripheral insulin sensitivity in equine pituitary pars intermedia dysfunction.
    Klinkhamer K; Menheere PP; van der Kolk JH
    Vet Q; 2011 Mar; 31(1):19-28. PubMed ID: 22029818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma fructosamine concentrations in horses with pituitary pars intermedia dysfunction with and without laminitis.
    Knowles EJ; Menzies-Gow NJ; Mair TS
    Equine Vet J; 2014 Mar; 46(2):249-51. PubMed ID: 23663105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equine pituitary pars intermedia dysfunction.
    McFarlane D
    Vet Clin North Am Equine Pract; 2011 Apr; 27(1):93-113. PubMed ID: 21392656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lumbar vertebral bone density is decreased in horses with pituitary pars intermedia dysfunction.
    Colbath AC; Fortin JS; Burglass CM; Panek C; Vergara-Hernandez FB; Johnson TN; Robison CA; Logan AA; Nelson NA; Nielsen BD; Schott HC
    Equine Vet J; 2024 Mar; 56(2):368-376. PubMed ID: 38151767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships of inflamm-aging with circulating nutrient levels, body composition, age, and pituitary pars intermedia dysfunction in a senior horse population.
    Siard-Altman MH; Harris PA; Moffett-Krotky AD; Ireland JL; Betancourt A; Barker VD; McMurry KE; Reedy SE; Adams AA
    Vet Immunol Immunopathol; 2020 Mar; 221():110013. PubMed ID: 32058159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.